| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/16/2001 | WO2001009096A3 Potassium channel openers |
| 08/16/2001 | WO2001007628A3 Human synthetases |
| 08/16/2001 | WO2001002569A3 Human immune response molecules |
| 08/16/2001 | US20010014689 Nervous system disorders |
| 08/16/2001 | US20010014677 Restenosis, kidney diseases, lung diseases |
| 08/16/2001 | US20010014334 Methods and materials for the treatment of prostatic carcinoma |
| 08/16/2001 | EP1123705A1 Pharmaceutical combinations for treating lower urinary tract disfunctions |
| 08/16/2001 | EP1123392A1 Prv-1 gene and the use thereof |
| 08/16/2001 | EP1123368A1 Method of extracting lipids from marine and aquatic animal tissues |
| 08/16/2001 | EP1123297A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123296A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 08/16/2001 | EP1123292A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123283A1 Thiazole-derivatives |
| 08/16/2001 | EP1123279A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123276A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 08/16/2001 | EP1123269A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123268A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123267A1 New compounds, their preparation and use |
| 08/16/2001 | EP1035851B1 Endothelin receptor antagonists for combating hyperlipidaemia |
| 08/16/2001 | EP0944388A4 Inhibitors of farnesyl-protein transferase |
| 08/16/2001 | DE10006836A1 Therapeutic treatment of bed-wetting using polyunsaturated fatty acids, e.g. eicosapentaenoic acid, administered as capsules containing fish oil concentrate |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2416343A1 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 08/16/2001 | CA2400299A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | CA2399795A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury |
| 08/16/2001 | CA2399396A1 Tnf- .alpha. inhibitors |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | CA2398007A1 Use of pyrimidine endothelin antagonists in companion animals |
| 08/15/2001 | CN1308677A Human tumour-derived polyptde hormone phosphatonin |
| 08/15/2001 | CN1308632A 'Beta'-carboline compound |
| 08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
| 08/15/2001 | CN1308536A Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 08/15/2001 | CN1069535C Clinical medicinal prepns. contg. flavongly coside extracted for persimmon leaves, and process for preparing same |
| 08/15/2001 | CN1069523C Application of alginic polysaccharide sulfate in preparation of medicine for treating renal failure |
| 08/14/2001 | US6274618 Administering (-)-cis-6-phenyl-5-(4-(2-pyrrolidin-1-yl-ethoxy)-phenyl)-5,6,7,8 -tetrahydronphthalen-2-ol to treat vaginal dryness, itching, or painful intercourse |
| 08/14/2001 | US6274583 Alpha 1a adrenergic receptor antagonists |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057175A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057078A1 Process for producing dialytic amyloid fiber polymerization nuclei, method of screening remedies for dialytic amyloidosis and remedies for dialytic amyloidosis |
| 08/09/2001 | WO2001057044A1 Pyridoxazine derivatives |
| 08/09/2001 | WO2001057039A1 Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-ht7 receptor |
| 08/09/2001 | WO2001057036A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057025A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057023A1 Heterocyclic amide derivatives |
| 08/09/2001 | WO2001057022A2 Pyrazole compositions useful as inhibitors of erk |
| 08/09/2001 | WO2001057008A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | WO2001057002A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 08/09/2001 | WO2001056981A1 Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives |
| 08/09/2001 | WO2001019814A3 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 08/09/2001 | WO2001004318A3 Myxoma virus genes for immune modulation |
| 08/09/2001 | WO2001002017A3 Erythropoietin conjugates with polyethylenglycol |
| 08/09/2001 | WO2000073324A9 Modulation of gene expression in gastrointestinal inflammation |
| 08/09/2001 | WO2000055072A3 Aerosol metering valve |
| 08/09/2001 | WO2000005224A3 Heterocyclic derivatives and their use as integrin inhibitor |
| 08/09/2001 | US20010012836 Determining the presence or absence of a mutation in the nucleotide sequence or absence of a mutation in nucleotide sequence encoding the specific polypeptides in the genome of the subject and analyzing for presence of polypeptide |
| 08/09/2001 | CA2399649A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2399644A1 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | CA2399545A1 Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-ht7 receptor |
| 08/09/2001 | CA2399214A1 Novel heterocyclic amide derivatives |
| 08/09/2001 | CA2399083A1 Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives |
| 08/09/2001 | CA2398754A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | CA2398674A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 08/08/2001 | EP1122253A1 Quinazolinone derivatives |
| 08/08/2001 | EP1121454A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 08/08/2001 | EP1121430A1 Human isre-binding protein |
| 08/08/2001 | EP1121419A1 Tnfr related gene 12 |
| 08/08/2001 | EP1121360A1 Il-8 receptor antagonists |
| 08/08/2001 | EP1121116A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 08/08/2001 | EP1121111A2 Compounds for the treatment of weight loss |
| 08/08/2001 | EP1121099A1 Pharmaceutical composition with gastric residence and controlled release |
| 08/08/2001 | CN1307643A Human BMP-7 promoter and method for exploring bone-related substance by using the same |
| 08/08/2001 | CN1307632A Ependymal neural stem cells and method for their isolation |
| 08/08/2001 | CN1307584A Macrolide LHRH antagonists |
| 08/08/2001 | CN1307571A Guanidine derivatives |
| 08/08/2001 | CN1306847A Ointment for treating prostatitis and its usage |
| 08/08/2001 | CN1069317C Novel indane-2-mercaptoacetamide disulfide derivs, useful as inhibitors of enkephaliinase |
| 08/08/2001 | CN1069312C Substituted imidogen sulfamide, its preparation, use and medicines containing the same |
| 08/07/2001 | US6271261 Chemokine mediated diseases, binding interleukins or beta-receptors and administering to mammals |
| 08/07/2001 | US6271248 Substituted biphenysulfonamide endothelin antagonists |
| 08/07/2001 | US6271245 Hydroxamic acid derivatives |
| 08/07/2001 | US6270994 Smad6 and uses thereof |
| 08/07/2001 | US6270992 Histidine kinase of Staphylococcus aureus |
| 08/07/2001 | CA2015296C Pyranyl cyanoguanidine derivatives |
| 08/02/2001 | WO2001055178A2 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | WO2001055152A1 BENZOXATHIEPINO[3,4-b]PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS |
| 08/02/2001 | WO2001055134A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vassopressin receptors |
| 08/02/2001 | WO2001055130A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
| 08/02/2001 | WO2001055122A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 08/02/2001 | WO2001055121A1 Azepine derivatives |
| 08/02/2001 | WO2001055119A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 08/02/2001 | WO2001055112A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 08/02/2001 | WO2001054728A1 NOVEL REMEDIES WITH THE USE OF β3 AGONIST |
| 08/02/2001 | WO2001054706A2 Method for treating kidney disorders |
| 08/02/2001 | WO2001054694A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method |
| 08/02/2001 | WO2001014548A3 New g-protein coupled receptor and dna sequences thereof |
| 08/02/2001 | WO2001012189A8 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/02/2001 | WO2001004305A3 Human proteins involved in detoxification |
| 08/02/2001 | WO2000067847A3 Use of dopamine d3 receptor ligands for producing medicaments for treating kidney disorders |
| 08/02/2001 | WO2000066564A8 Benzimidazolones and analogues and their use as progesterone receptor ligands |